Literature DB >> 33608693

Author Correction: Conservation of copy number profiles during engraftment and passaging of patient-derived cancer xenografts.

Xing Yi Woo1, Jessica Giordano2,3, Anuj Srivastava1, Zi-Ming Zhao1, Michael W Lloyd4, Roebi de Bruijn5, Yun-Suhk Suh6, Rajesh Patidar7, Li Chen7, Sandra Scherer8, Matthew H Bailey8,9, Chieh-Hsiang Yang8, Emilio Cortes-Sanchez8, Yuanxin Xi10, Jing Wang10, Jayamanna Wickramasinghe11, Andrew V Kossenkov11, Vito W Rebecca11, Hua Sun12, R Jay Mashl12, Sherri R Davies12, Ryan Jeon13, Christian Frech13, Jelena Randjelovic13, Jacqueline Rosains13, Francesco Galimi2,3, Andrea Bertotti2,3, Adam Lafferty14, Alice C O'Farrell14, Elodie Modave15,16, Diether Lambrechts15,16, Petra Ter Brugge5, Violeta Serra17, Elisabetta Marangoni18, Rania El Botty18, Hyunsoo Kim1, Jong-Il Kim6, Han-Kwang Yang6, Charles Lee1,19,20, Dennis A Dean13, Brandi Davis-Dusenbery13, Yvonne A Evrard7, James H Doroshow21, Alana L Welm8, Bryan E Welm8,22, Michael T Lewis23, Bingliang Fang24, Jack A Roth24, Funda Meric-Bernstam25, Meenhard Herlyn11, Michael A Davies26, Li Ding12, Shunqiang Li12, Ramaswamy Govindan12, Claudio Isella2,3, Jeffrey A Moscow27, Livio Trusolino2,3, Annette T Byrne14, Jos Jonkers5, Carol J Bult4, Enzo Medico28,29, Jeffrey H Chuang30.   

Abstract

Entities:  

Year:  2021        PMID： 33608693      PMCID： PMC8110476          DOI： 10.1038/s41588-021-00811-4

Source DB:  PubMed          Journal:  Nat Genet        ISSN： 1061-4036            Impact factor:   38.330


× No keyword cloud information.
Correction to: Nature Genetics 10.1038/s41588-020-00750-6, published online 7 January 2021. This paper was originally published without open access. As of the date of this correction, the paper is available online as an open-access paper under a Creative Commons Attribution 4.0 International License.
  1 in total

Review 1.  Patient-derived tumor models are attractive tools to repurpose drugs for ovarian cancer treatment: pre-clinical updates.

Authors:  Magdalena Cybula; Magdalena Bieniasz
Journal:  Oncotarget       Date:  2022-03-24
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.